6.6% of non-users In other words, GLP-1 medications were associated with: ~30% higher risk of osteoporosis ~12% higher risk of gout These results do not prove the medications directly cause the conditions , but they suggest a possible relationship worth further investigation
Safety depends on the specific peptide, dose, formulation, sourcing, route of administration, and patient health history
Dose-and time-dependent expression of aryl hydrocarbon receptor ( AhR ) and aryl hydrocarbon receptor nuclear translocator ( ARNT ) in PCB-, B[ a ]P-, and TBT-exposed intertidal copepod Tigriopus japonicus
Policy discussions should focus on supporting rigorous trials and ensuring that future decisions balance possible addiction-related benefits with cost, access, and medication safety
Patients on Saxenda lost between 5-10% of their body weight during a 56-week clinical trial